COVID-19 Pandemic Delays FDA Review of Vaping Products
Federal court has granted FDA request to delay May 12 deadline to Sept. 9
FRIDAY, April 24, 2020 (HealthDay News) -- A review of vaping products has been delayed by the COVID-19 outbreak, the U.S. Food and Drug Administration announced Thursday.
The agency said that a federal court granted its request to delay the May 12 deadline for companies to submit applications for vaping products to Sept. 9, the Associated Press reported.
The FDA said the pandemic made it difficult for its staff and companies to meet the original deadline for the review that is part of the agency's plans to regulate vaping products such as electronic cigarettes and flavored solutions.
Last year, health advocacy groups sued the FDA to speed up its review of vaping products and the court ruled that the agency must set the May 12 deadline for product applications, the AP reported.